BMO Capital Reiterates Buy Rating for CareTrust REIT
BMO Capital maintains its buy rating on CareTrust REIT, Inc. with a price target of $47, a 26.82% upside from the current price.
Key Points
- BMO Capital reiterated its buy rating for CareTrust REIT, Inc. (NYSE: CTRE) with a price target of $47 on June 15, 2026.
- BMO Capital's $47 price target implies 26.82% upside from CareTrust REIT, Inc.'s ($CTRE) current $37.06 share price.
- Shares of CareTrust REIT are trading around $36.85 with a market cap of $8.71 billion and a P/E ratio of 23.32.
- BlackRock and Vanguard made notable moves in CareTrust, with BlackRock reducing its stake by over 5.8 million shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
BMO Capital reiterated its buy rating on CareTrust REIT, Inc. (NYSE: CTRE) on June 15, 2026. Analyst Juan Sanabria set a price target of $47, maintaining confidence in the stock's potential.
Other Institutional Activity in CareTrust REIT
BlackRock, Inc. reduced its holdings in CareTrust by 5,872,569 shares, leaving it with 35,876,497 shares valued at roughly $1.31 billion. Vanguard Portfolio Management LLC established a new position, acquiring 19,901,022 shares worth about $729.4 million. State Street Corp trimmed its stake by 390,942 shares, ending with 12,035,271 shares valued at approximately $445.7 million. Cohen & Steers, Inc. cut its position by 4,493,546 shares, resulting in 11,983,376 shares valued at $439.2 million. Wellington Management Group LLP also reduced its stake by 534,884 shares, holding 11,821,082 shares valued at $433.2 million.
CareTrust REIT, Inc. Stock Down 4.9%
Shares of NYSE:CTRE traded near $36.85. CareTrust REIT has a market cap of $8.71 billion, a P/E ratio of 23.32, and a forward P/E of 21.15. The stock's beta is 0.786, indicating lower volatility compared to the market. Its 52-week range is $27.81 to $43.08, with a 50-day moving average of $39.47 and a 200-day moving average of $37.36. The company's current ratio is 2.11, quick ratio is 1.75, and its debt-to-equity ratio stands at 71.95.
$CTRE price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
In the latest quarter, CareTrust REIT reported revenue of $522.6 million, reflecting a 3.2% growth. The company achieved a net margin of 64.1% and a return on equity of 9.4%. Earnings per share stood at $1.58. The next earnings report is expected on August 10, 2026.
Dividend
CareTrust REIT offers an annual dividend rate of $1.56, yielding 4.23%. The dividend payout ratio is 88.29%.
Insider Buying and Selling at CareTrust REIT, Inc.
On January 31, 2026, CIO and Secretary James Callister bought 58,379 shares and sold 46,267 shares in separate transactions. Chief Accounting Officer Lauren Beale sold 12,208 shares at an average price of $37.34. President and CEO David Sedgwick purchased 99,240 shares.
Analysts Set New Price Targets
On June 15, 2026, BMO Capital maintained its buy rating with a $47 price target. Wells Fargo also maintained a buy rating with the same target on June 1, 2026. Mizuho initiated coverage with a buy rating and a $42 target on April 2, 2026. The consensus among analysts is a strong buy, with a mean target price of $45.42.
About CareTrust REIT, Inc.
CareTrust REIT, Inc. is a real estate investment trust based in Dana Point, California. It focuses on owning and leasing skilled nursing, senior housing, and other healthcare-related properties. The company operates over 407 facilities with a significant presence in California, the U.K., Texas, and Tennessee. Led by CEO David M. Sedgwick, CareTrust REIT continues to expand its portfolio in the healthcare real estate sector.
Bottom Line
BMO Capital's reiteration of a buy rating for CareTrust REIT, Inc. reflects continued confidence in the company's growth prospects. With a stable market position and a strong dividend yield, the stock remains a point of interest for many investors. As a reminder, analyst ratings are based on past data and should be considered as part of a broader investment strategy.
Get CareTrust REIT, Inc. alerts
New 13F filings, insider trades, and analyst moves on $CTRE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.